Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: A case-control study nested in the β-carotene and retinol efficacy trial cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1413-1418

  Spitz, Margaret R ^a   Barnett, Matt J ^b   Goodman, Gary E ^b   Thornquist, Mark D ^b   Wu, Xifeng ^a   Pollak, Michael ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; RETINOL; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOMA; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ETHNOLOGY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; STATISTICAL SIGNIFICANCE;

AGED; ANTIOXIDANTS; BETA CAROTENE; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SMOKING; STATISTICS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; VITAMIN A;

EID: 0036847606     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev., 16: 3-34, 1995
2. LeRoith, D., Wemer, H., Beitner-Johnson, D., and Roberts, C. T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16: 143-163, 1995
3. Stiles, A. D., and D'Ercole, A. J. The insulin-like growth factors and the lung. Am. J. Respir. Cell. Mol. Biol., 3: 93-100, 1990
4. Juul, A., Dalgaard, P., Blum, W. F., Bang, P., Hall, K., Michaelsen, K. F., Muller, J., and Skakkebaek, N. E. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab., 80: 2534-2542, 1995
5. Reeve, J. G., Brinkman, A., Hughes, S., Mitchell, J., Schwander, J., and Bleehen, N. M. Expression of insulin-like growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. J. Natl. Cancer Inst. (Bethesda), 84: 628-634, 1992
6. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. Plasma insulin-like growth factor-I and prostrate cancer risk: A prospective study. Science (Wash. DC), 279: 563-566, 1998
7. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998
8. Kaaks, R., Tonioto, P., Akhmedkhanov, A., Lukanova, A., Biessy, C., Dechaud, H., Rinaldi, S., Zeleniuch-Jacquotte, A., Shore, R. E., and Riboli, E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J. Natl. Cancer Inst. (Bethesda), 92: 1592-1600, 2000
9. Toniolo, P., Bruning, P. F., Akhmedkhanov, A., Bonfrer, J. M., Koenig, K. L., Lukanova, A., Shore, R. E., and Zeleniuch-Jacquotte, A. Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer, 88: 828-832, 2000
10. Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., and Stampfer, M. J. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. (Bethesda), 91: 620-625, 1999
11. Pollak, M. Insulin-like growth factor physiology and cancer risk. Eur. J. Cancer. 36: 1224-1228, 2000
12. Pollak, M. Insulin-like growth factors (IGFs) and prostate cancer. Epidemiol. Rev., 23: 59-66, 2001
13. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489, 2000
14. Giovannucci, E., Pollak, M., Platz, E., Willett, W., Stampfer, M., Majeed, N., Colditz, G., Speizer, F., and Hankinson. S. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomark. Prev., 9: 345-349, 2000
15. Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., and Wu, X. Plasma levels of insulin-like growth factor-I and lung cancer risk: Case-control analysis. J. Natl. Cancer Inst., 91: 151-156, 1999
16. Thornquist, M. D., Omenn, G. S., Goodman, G. E., Grizzle, J. E., Rosenstock, L., Barnhart, S., Anderson, G. L., Hammar, S., Balmes, J., Cherniack, M., Cone, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Jr., Valanis, B., and Williams, J. H., Jr. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Controlled Clin. Trials, 14: 308-324, 1993
17. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S., and Hammar, S. Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 334: 1150-1155, 1996
18. Landin-Wilhelmsen, P. K., Wilhelmsen, L., Lappas, G., Rosen, T., Lindstedt, G., Lundberg, P. A., and Bengtsson, B. A. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin. Endocrinol., 41: 351-357, 1994
19. Lukanova, A., Toniolo, P., Akhmedkhanov, A., Biessy, C., Haley, N. J., Shore, R. E., Riboli, E., Rinaldi, S., and Kaaks, R. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. Int. J. Cancer, 92: 888-892, 2001
20. Goodman-Gruen, D., and Barrett-Connor, E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am. J. Epidemiol., 145: 970-976, 1997
21. London, S. J., Yuan, J-M., Travlos, G. S., Gao, Y-T., Wilson, R. E., Ross, R. K., and Yu, M. C. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J. Natl. Cancer Inst. (Bethesda), 94: 749-754, 2002
22. Favoni, R. E., de Cupis, A., Ravera, F., Cantoni, C., Pirani, P., Ardizzoni, A., Noonan, D., and Biassoni, R. Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. Int. J. Cancer, 56: 858-866, 1994
23. Quinn, K. A., Treston, A. M., Unsworth, E. J., Miller, M. J., Vos, M., Grimley, C., Battey, J., Mulshine, J. L., and Cuttitta, F. Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem., 271: 11477-11483, 1996
24. Jaques, G., Rotsch, M., Wegmann, C., Worsch, U., Maasberg, M., and Havemann, K. Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cell lines. Exp. Cell Res., 176: 336-343, 1988
25. Kaiser, U., Schardt, C., Brandscheidt, D., Wollmer, E., and Havemann, K. Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer. J. Cancer Res. Clin. Oncol., 119: 665-668, 1993
26. Lee, C. T., Wu, S., Gabrilovich, D., Chen, H., Nadaf-Rahrov, S., Ciernik, I. F., and Carbone, D. P. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cells. Cancer Res., 56: 3038-3041, 2001
27. Jemstrom, H., Deal, C., Wilkin, F., Chu, W., Tao, Y., Majeed, N., Hudson, T., Narod, S. A., and Pollak, M. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol. Biomark. Prev., 10: 377-384, 2001
28. Wu, X., Yu, H., Amos, C. I., Hong, W. K., and Spitz, M. R. Joint effect of insulin-like growth actors and mutagen sensitivity in lung cancer risk. J. Natl. Cancer Inst. (Bethesda), 92: 737-743, 2000
29. Hebert, P. R., Ajani, U., Cook, N. R., Lee, I. M., Chan, K. S., and Hennekens, C. H. Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control, 8: 591-597, 1997
30. Davey Smith, G., Shipley, M., and Leon, D. A. Height and mortality from cancer among men: Prospective observational study. Br. Med. J., 317: 1351-1352, 1998
31. Gunnell, D. J., Smith, G. D., Holly, J. M. P., and Frankel, S. Leg length and risk of cancer in the Boyd Orr cohort. Br. Med. J., 317: 1350-1351, 1998
32. Frankel, S., Gunnell, D. J., Peters, T. J., Maynard, M., and Davey Smith, G. Childhood energy intake and adult mortality from cancer: The Boyd Orr cohort study. Br. Med. J., 316: 499-504, 1998
33. Albanes, D., Jones, D. Y., Schatzkin, A., Micozzi, M. S., and Taylor, P. R. Adult stature and risk of cancer. Cancer Res., 48: 1658-1662, 1988